Variant report

Variant	esv3384067
Chromosome Location	chr6:35462874-35466272
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:651)
CpG islands
(count:550)
Chromatin interactive
region (count:44)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:651 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr6:35465448-35466198	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF3	chr6:35466262-35466497	K562	blood:	n/a	n/a
3	BACH1	chr6:35465018-35466097	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr6:35465385-35465467	K562	blood:	n/a	n/a
5	BACH1	chr6:35463553-35463623	K562	blood:	n/a	n/a
6	BACH1	chr6:35463936-35464216	H1-hESC	embryonic stem cell:	n/a	n/a
7	BHLHE40	chr6:35464925-35466949	K562	blood:	n/a	chr6:35465324-35465340 chr6:35466465-35466481
8	BHLHE40	chr6:35463875-35464243	K562	blood:	n/a	n/a
9	BHLHE40	chr6:35465035-35465358	GM12878	blood:	n/a	chr6:35465324-35465340
10	CBX3	chr6:35465319-35466849	K562	blood:	n/a	n/a
11	CBX3	chr6:35465435-35465782	K562	blood:	n/a	n/a
12	CBX3	chr6:35463719-35464260	K562	blood:	n/a	n/a
13	CCNT2	chr6:35464027-35466338	K562	blood:	n/a	chr6:35464480-35464489 chr6:35464739-35464748 chr6:35464464-35464473 chr6:35464364-35464373
14	CEBPB	chr6:35466218-35466531	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr6:35466183-35466561	K562	blood:	n/a	n/a
16	CEBPB	chr6:35462803-35462940	K562	blood:	n/a	n/a
17	CEBPB	chr6:35466247-35466473	HepG2	liver:	n/a	n/a
18	CEBPB	chr6:35466208-35466510	K562	blood:	n/a	n/a
19	CEBPB	chr6:35462809-35463009	HepG2	liver:	n/a	n/a
20	CEBPD	chr6:35465562-35465982	HepG2	liver:	n/a	n/a
21	CEBPD	chr6:35464085-35464869	HepG2	liver:	n/a	n/a
22	CEBPD	chr6:35464886-35465232	HepG2	liver:	n/a	n/a
23	CHD1	chr6:35465591-35466082	H1-hESC	embryonic stem cell:	n/a	n/a
24	CHD2	chr6:35465678-35465729	K562	blood:	n/a	n/a
25	CHD2	chr6:35464391-35466037	Hela-S3	cervix:	n/a	chr6:35465063-35465073 chr6:35465017-35465027 chr6:35465585-35465595 chr6:35465520-35465530
26	CHD2	chr6:35465634-35465895	H1-hESC	embryonic stem cell:	n/a	n/a
27	CHD2	chr6:35464140-35464171	Hela-S3	cervix:	n/a	n/a
28	CHD2	chr6:35464674-35464717	H1-hESC	embryonic stem cell:	n/a	n/a
29	CREB1	chr6:35463565-35466162	HepG2	liver:	n/a	n/a
30	CREB1	chr6:35464980-35465367	A549	lung:	n/a	n/a
31	CTBP2	chr6:35465183-35466438	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr6:35465608-35465618	A549	lung:	n/a	n/a
33	CTCF	chr6:35464560-35464710	SK-N-SH_RA	brain:	n/a	n/a
34	CTCF	chr6:35464560-35464710	AG10803	skin:	n/a	n/a
35	CTCF	chr6:35465600-35465750	HCPEpiC	choroid plexus:	n/a	n/a
36	CTCF	chr6:35464580-35464730	AoAF	blood vessel:	n/a	n/a
37	CTCF	chr6:35465547-35465712	LNCaP	prostate:	n/a	n/a
38	CTCF	chr6:35464560-35464710	HEEpiC	esophagus:	n/a	n/a
39	CTCF	chr6:35464560-35464710	GM12875	blood:	n/a	n/a
40	CTCF	chr6:35464533-35464855	K562	blood:	n/a	n/a
41	CTCF	chr6:35464540-35464690	AG04449	skin:	n/a	n/a
42	CTCF	chr6:35464480-35464630	SK-N-SH_RA	brain:	n/a	n/a
43	CTCF	chr6:35465580-35465635	H1-hESC	embryonic stem cell:	n/a	n/a
44	CTCF	chr6:35466100-35466250	Caco-2	colon:	n/a	n/a
45	CTCF	chr6:35464532-35464890	K562	blood:	n/a	n/a
46	CTCF	chr6:35465540-35465690	HMEC	breast:	n/a	n/a
47	CTCF	chr6:35465520-35465670	HEEpiC	esophagus:	n/a	n/a
48	CTCF	chr6:35464480-35464750	NHLF	lung:	n/a	n/a
49	CTCF	chr6:35465540-35465690	SAEC	small airway:	n/a	n/a
50	CTCF	chr6:35465540-35465690	HAc	cerebellar:	n/a	n/a

(count:550 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:35466268-35466318	BE2_C	brain:	n/a
2	chr6:35466268-35466318	BE2_C	brain:	n/a
3	chr6:35465342-35465392	Hepatocyte	liver:	n/a
4	chr6:35466014-35466064	AG10803	skin:	n/a
5	chr6:35464939-35464989	Hela-S3	cervix:	n/a
6	chr6:35464571-35464621	ovcar-3	ovarian:	n/a
7	chr6:35466268-35466318	PFSK-1	brain:	n/a
8	chr6:35464571-35464621	SKMC	muscle:	n/a
9	chr6:35463625-35463675	HEEpiC	esophagus:	n/a
10	chr6:35463625-35463675	U87	brain:	n/a
11	chr6:35463625-35463675	HepG2	liver:	n/a
12	chr6:35466014-35466064	Jurkat	blood:	n/a
13	chr6:35465342-35465392	HCF	heart:	n/a
14	chr6:35466014-35466064	NB4	blood:	n/a
15	chr6:35466268-35466318	LNCaP	prostate:	n/a
16	chr6:35464304-35464354	MCF-7	breast:	n/a
17	chr6:35464571-35464621	GM19239	blood:	n/a
18	chr6:35464536-35464586	AG04450	lung:	fetal
19	chr6:35464571-35464621	AG10803	skin:	n/a
20	chr6:35464571-35464621	SK-N-MC	brain:	n/a
21	chr6:35464304-35464354	GM12891	blood:	n/a
22	chr6:35465342-35465392	AG04449	skin:	fetal
23	chr6:35465845-35465895	SKMC	muscle:	n/a
24	chr6:35463625-35463675	HRCEpiC	kidney:	n/a
25	chr6:35464571-35464621	PANC-1	pancreas:	n/a
26	chr6:35463625-35463675	AG09309	skin:	n/a
27	chr6:35464939-35464989	MCF10A-Er-Src	breast:	n/a
28	chr6:35466014-35466064	K562	blood:	n/a
29	chr6:35464536-35464586	NB4	blood:	n/a
30	chr6:35466014-35466064	BE2_C	brain:	n/a
31	chr6:35465845-35465895	HCM	heart:	n/a
32	chr6:35464571-35464621	MCF10A-Er-Src	breast:	n/a
33	chr6:35463625-35463675	AG10803	skin:	n/a
34	chr6:35465845-35465895	AoSMC	blood vessel:	n/a
35	chr6:35464571-35464621	HEEpiC	esophagus:	n/a
36	chr6:35464304-35464354	NT2-D1	testis:	n/a
37	chr6:35463625-35463675	ProgFib	skin:	n/a
38	chr6:35464536-35464586	HAEpiC	amniotic membrane:	n/a
39	chr6:35464304-35464354	PFSK-1	brain:	n/a
40	chr6:35465342-35465392	Jurkat	blood:	n/a
41	chr6:35466268-35466318	HCF	heart:	n/a
42	chr6:35466014-35466064	RPTEC	kidney:	n/a
43	chr6:35466014-35466064	HCF	heart:	n/a
44	chr6:35464536-35464586	HRE	kidney:	n/a
45	chr6:35464939-35464989	NHBE	bronchial:	n/a
46	chr6:35464571-35464621	NHDF-neo	bronchial:	n/a
47	chr6:35465342-35465392	HRPEpiC	eye:	n/a
48	chr6:35464304-35464354	HEEpiC	esophagus:	n/a
49	chr6:35464939-35464989	SK-N-SH_RA	brain:	n/a
50	chr6:35464939-35464989	ovcar-3	ovarian:	n/a

(count:44 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:7387197..7388120-chr6:35464620..35465289,2	Hela-S3	cervix:
2	chr6:35463384..35465009-chr6:35703029..35705389,2	K562	blood:
3	chr6:35310114..35311915-chr6:35462651..35465491,3	MCF-7	breast:
4	chr6:35464935..35465692-chr7:44835784..44836776,2	Hela-S3	cervix:
5	chr6:35465886..35468037-chr6:35705048..35706925,2	K562	blood:
6	chr6:35464241..35466956-chr6:35695881..35700309,4	MCF-7	breast:
7	chr6:35310116..35312027-chr6:35462385..35465150,2	MCF-7	breast:
8	chr1:210547375..210547960-chr6:35465386..35466203,2	Hela-S3	cervix:
9	chr20:47894747..47895275-chr6:35464852..35465455,2	Hela-S3	cervix:
10	chr11:33757381..33758237-chr6:35465059..35466295,3	Hela-S3	cervix:
11	chr6:35289938..35291662-chr6:35465459..35467668,2	K562	blood:
12	chr6:35227208..35228940-chr6:35464081..35465836,2	K562	blood:
13	chr6:35462682..35465009-chr6:35702407..35705389,2	K562	blood:
14	chr20:15349649..15350459-chr6:35465170..35465747,2	MCF-7	breast:
15	chr6:35464312..35466499-chr6:35694204..35696742,2	MCF-7	breast:
16	chr6:35465223..35467694-chr6:35696445..35698937,2	K562	blood:
17	chr6:35464601..35467910-chr6:35655207..35659461,3	K562	blood:
18	chr6:35465054..35467000-chr6:36192851..36194879,2	MCF-7	breast:
19	chr6:35270724..35273111-chr6:35465041..35467348,2	K562	blood:
20	chr6:35265003..35267090-chr6:35463346..35464932,2	K562	blood:
21	chr6:35423795..35426623-chr6:35465037..35468781,3	K562	blood:
22	chr19:11198114..11200950-chr6:35464173..35466447,2	K562	blood:
23	chr6:35310112..35312932-chr6:35464368..35466518,2	K562	blood:
24	chr6:35465446..35468035-chr6:35607430..35610345,2	K562	blood:
25	chr6:35465082..35466862-chr6:35699908..35701462,2	MCF-7	breast:
26	chr6:35463571..35465690-chr6:35654249..35656915,2	K562	blood:
27	chr6:35260813..35263112-chr6:35464822..35466518,2	K562	blood:
28	chr6:35225785..35227535-chr6:35464894..35467017,2	K562	blood:
29	chr6:35264944..35267460-chr6:35465302..35468823,3	MCF-7	breast:
30	chr1:153699734..153700587-chr6:35465219..35465916,2	Hela-S3	cervix:
31	chr6:35310058..35310620-chr6:35464293..35465068,2	K562	blood:
32	chr6:35376688..35379327-chr6:35465068..35467470,3	K562	blood:
33	chr6:35462442..35464169-chr6:35698121..35700196,2	MCF-7	breast:
34	chr5:130531404..130532060-chr6:35465194..35466059,2	Hela-S3	cervix:
35	chr5:43514826..43515720-chr6:35464905..35465668,2	Hela-S3	cervix:
36	chr2:176033099..176033744-chr6:35465562..35466338,2	Hela-S3	cervix:
37	chr6:35419956..35422517-chr6:35464991..35466898,2	MCF-7	breast:
38	chr6:35418643..35423313-chr6:35462563..35468017,10	K562	blood:
39	chr17:36905700..36906366-chr6:35464667..35465593,2	Hela-S3	cervix:
40	chr21:46237169..46238057-chr6:35464670..35465479,2	Hela-S3	cervix:
41	chr6:35263661..35265616-chr6:35463054..35466039,2	MCF-7	breast:
42	chr6:35465083..35467815-chr6:35613967..35615894,2	MCF-7	breast:
43	chr6:35435808..35436604-chr6:35464010..35464598,3	Hela-S3	cervix:
44	chr6:35465758..35466302-chr9:35603362..35604311,2	Hela-S3	cervix:

No data

Variant related genes	Relation type
TEAD3	TF binding region
TEAD3	CpG island
ENSG00000172244	chromatin interactions
ENSG00000112033	chromatin interactions
ENSG00000177410	chromatin interactions
ENSG00000184900	chromatin interactions
ENSG00000065029	chromatin interactions
ENSG00000200972	chromatin interactions
ENSG00000023892	chromatin interactions
ENSG00000115966	chromatin interactions
ENSG00000196262	chromatin interactions
ENSG00000130164	chromatin interactions
ENSG00000248240	chromatin interactions
ENSG00000157343	chromatin interactions
ENSG00000143624	chromatin interactions
ENSG00000124201	chromatin interactions
ENSG00000181222	chromatin interactions
ENSG00000056661	chromatin interactions
ENSG00000085063	chromatin interactions
ENSG00000174282	chromatin interactions
ENSG00000112039	chromatin interactions
ENSG00000198755	chromatin interactions
ENSG00000096060	chromatin interactions
ENSG00000232909	chromatin interactions

Extended variants
information (count: 116 )
Associated
traits (count: 104 )

Variant overlapped rSNPs/rCNVs (count:116 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs535934700	chr6:35462882-35462883	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs554277990	chr6:35462903-35462904	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs146398713	chr6:35462904-35462905	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs139745632	chr6:35462922-35462923	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs372017769	chr6:35462956-35462957	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs556729770	chr6:35462972-35462973	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs367761322	chr6:35462984-35462985	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs578151309	chr6:35462994-35462995	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs545685384	chr6:35463004-35463005	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs371671513	chr6:35463005-35463006	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs554203522	chr6:35463051-35463052	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs202005236	chr6:35463055-35463056	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs543124748	chr6:35463064-35463065	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs561342223	chr6:35463102-35463103	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs114753628	chr6:35463150-35463151	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs575573290	chr6:35463158-35463159	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs144486807	chr6:35463169-35463170	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs554184669	chr6:35463175-35463176	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs369358298	chr6:35463188-35463189	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs377014095	chr6:35463192-35463193	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs369922743	chr6:35463201-35463202	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs7744287	chr6:35463202-35463203	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
23	rs12205084	chr6:35463238-35463239	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs565319403	chr6:35463257-35463258	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs529669130	chr6:35463305-35463306	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs151098375	chr6:35463354-35463355	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs189902546	chr6:35463375-35463376	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs537156542	chr6:35463393-35463394	Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs561123072	chr6:35463401-35463402	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs74869746	chr6:35463402-35463403	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs60375063	chr6:35463410-35463411	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs554534846	chr6:35463513-35463514	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs72894791	chr6:35463517-35463518	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs182054321	chr6:35463535-35463536	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs149916718	chr6:35463558-35463559	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs543081057	chr6:35463565-35463566	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs543943222	chr6:35463581-35463582	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs564922963	chr6:35463610-35463611	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs577004148	chr6:35463683-35463684	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs111444760	chr6:35463786-35463787	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs540903749	chr6:35463790-35463791	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs559193356	chr6:35463814-35463815	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs369294075	chr6:35463848-35463849	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs187061185	chr6:35463979-35463980	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs373470644	chr6:35463986-35463987	Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs529953771	chr6:35464012-35464013	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
47	rs532085505	chr6:35464030-35464031	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
48	rs547740279	chr6:35464110-35464111	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
49	rs562945561	chr6:35464152-35464153	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
50	rs530516154	chr6:35464159-35464160	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:104)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Autoimmune disease	19135723	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:576 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:35455400-35463400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
2	chr6:35456200-35464400	Enhancers	Primary hematopoietic stem cells short term culture	blood
3	chr6:35457200-35463200	Enhancers	Ovary	ovary
4	chr6:35457200-35463400	Enhancers	Lung	lung
5	chr6:35457200-35463600	Enhancers	Pancreas	Pancrea
6	chr6:35457600-35463000	Enhancers	NHDF-Ad	bronchial
7	chr6:35458400-35463400	Enhancers	Cortex derived primary cultured neurospheres	brain
8	chr6:35458400-35463800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr6:35458400-35463800	Weak transcription	Brain Angular Gyrus	brain
10	chr6:35458600-35463000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr6:35458600-35463000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
12	chr6:35458600-35463200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
13	chr6:35458600-35463400	Weak transcription	Brain Substantia Nigra	brain
14	chr6:35458600-35463400	Enhancers	Left Ventricle	heart
15	chr6:35458600-35463800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr6:35458800-35463000	Enhancers	H1 Cell Line	embryonic stem cell
17	chr6:35458800-35463200	Enhancers	Fetal Intestine Large	intestine
18	chr6:35458800-35463200	Enhancers	Skeletal Muscle Female	skeletal muscle
19	chr6:35458800-35463400	Enhancers	Right Atrium	heart
20	chr6:35458800-35463600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr6:35458800-35463600	Weak transcription	Brain Anterior Caudate	brain
22	chr6:35458800-35463800	Weak transcription	Brain Hippocampus Middle	brain
23	chr6:35459400-35463200	Enhancers	Primary hematopoietic stem cells	blood
24	chr6:35459400-35463200	Enhancers	Liver	Liver
25	chr6:35459400-35463200	Enhancers	Right Ventricle	heart
26	chr6:35459800-35463000	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
27	chr6:35460000-35463600	Weak transcription	A549	lung
28	chr6:35460200-35463000	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr6:35460400-35463200	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr6:35460400-35463600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
31	chr6:35460600-35463400	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr6:35460600-35463800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
33	chr6:35460800-35463400	Weak transcription	K562	blood
34	chr6:35461000-35465000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
35	chr6:35461000-35465000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
36	chr6:35461200-35463000	Enhancers	Spleen	Spleen
37	chr6:35461200-35463400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr6:35461200-35463400	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
39	chr6:35461200-35463800	Bivalent Enhancer	Fetal Thymus	thymus
40	chr6:35461600-35463200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
41	chr6:35461600-35463200	Bivalent Enhancer	Fetal Muscle Leg	muscle
42	chr6:35461600-35463400	Enhancers	Primary T cells fromperipheralblood	blood
43	chr6:35461600-35463400	Enhancers	Adipose Nuclei	Adipose
44	chr6:35461600-35463400	Enhancers	Gastric	stomach
45	chr6:35461600-35463600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
46	chr6:35461600-35464000	Flanking Active TSS	Muscle Satellite Cultured Cells	--
47	chr6:35461800-35463000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
48	chr6:35461800-35463000	Enhancers	Stomach Mucosa	stomach
49	chr6:35461800-35463000	Enhancers	Hela-S3	cervix
50	chr6:35461800-35463400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links